  | Bayoudh, F., Giot, J.-B., Descy, J., Fontaine, C., Hayette, M.-P., Baron, F., WILLEMS, E., Beguin, Y., FRIPPIAT, F., & Servais, S. (March 2024). Oral minocycline as systemic therapy for uncomplicated venous access device-related bloodstream infection with coagulase-negative staphylococci after allogeneic hematopoietic cell transplantation. Current Research in Translational Medicine, 72 (1), 103422. doi:10.1016/j.retram.2023.103422  Peer Reviewed verified by ORBi |
 | El Moussaoui, M., Guiot, J., FRIPPIAT, F., & Darcis, G. (May 2023). Une cause émergente de fatigue et de douleurs chroniques : l’affection post-COVID-19 ou COVID long. Revue Médicale de Liège, 78 (5-6), 299 - 304. Editorial Reviewed verified by ORBi |
 | Pathak, G. A., Karjalainen, J., Stevens, C., Neale, B. M., Daly, M., Ganna, A., Andrews, S. J., Kanai, M., Cordioli, M., Polimanti, R., Harerimana, N., Pirinen, M., Liao, R. G., Chwialkowska, K., Trankiem, A., Balaconis, M. K., Nguyen, H., Solomonson, M., Veerapen, K., ... Baillie, J. K. (03 August 2022). A first update on mapping the human genetic architecture of COVID-19. Nature, 608, 1-E10. doi:10.1038/s41586-022-04826-7 Peer Reviewed verified by ORBi |
 | Layios, N., Visée, C., Mistretta, V., Denooz, R., Maes, N., Descy, J., Frippiat, F., Marchand, S., & Grégoire, N. (2022). Modelled target attainment after temocillin treatment in severe pneumonia: systemic and epithelial lining fluid pharmacokinetics of continuous versus intermittent infusions. Antimicrobial Agents and Chemotherapy, 0205221. doi:10.1128/AAC.02052-21 Peer Reviewed verified by ORBi |
 | Nakanishi, T., Pigazzini, S., Degenhardt, F., Cordioli, M., Butler-Laporte, G., Maya-Miles, D., Nafría-Jiménez, B., Bouysran, Y., Niemi, M., Palom, A., Ellinghaus, D., Khan, A., Martínez-Bueno, M., Rolker, S., Amitano, S., Tato, L. R., Fava, F., Spinner, C. D., Prati, D., ... consortium, C.-H. (October 2021). Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality. Journal of Clinical Investigation, Online ahead of print.. doi:10.1172/JCI152386 Peer Reviewed verified by ORBi |
 | GONCETTE, V., Layios, N., DESCY, J., & FRIPPIAT, F. (September 2021). Continuous infusion, therapeutic drug monitoring and outpatient parenteral antimicrobial therapy with ceftazidime/avibactam: a retrospective cohort study. Journal of Global Antimicrobial Resistance, 26, 15 - 19. doi:10.1016/j.jgar.2021.04.015 Peer Reviewed verified by ORBi |
  | Tchana-Sato, V., Hans, G., FRIPPIAT, F., ZEKHNINI, I., Dulgheru, R. E., Brüls, S., Durieux, R., LAVIGNE, J.-P., & Defraigne, J. (March 2021). Streptococcus agalactiae infective endocarditis: analysis of eight surgical cases from a single centre. Infectious Diseases, 53 (3), 189 - 195. doi:10.1080/23744235.2020.1863460 Peer Reviewed verified by ORBi |
 | Plum, P.-E., Maes, N., Sauvage, A.-S., Frippiat, F., Meuris, C., Uurlings, F., Lecomte, M., Léonard, P., Paquot, N., Fombellida, K., Vaira, D., Moutschen, M., & Darcis, G. (2021). Impact of switch from tenofovir disoproxil fumarate-based regimens to tenofovir alafenamide-based regimens on lipid profile, weight gain and cardiovascular risk score in people living with HIV. BMC Infectious Diseases, 21 (1), 910. doi:10.1186/s12879-021-06479-9 Peer Reviewed verified by ORBi |
 | Niemi, M., Gazon, H., JUSZCZAK, D., FADEUR, M., CAMBY, S., MEURIS, C., THYS, M., JACQUES, J., HENKET, M., BEGUIN, Y., Rahmouni, S., Lebrun, M., MOUTSCHEN, M., Misset, B., DARCIS, G., GUIOT, J., AZARZAR, S., DELLOT, P., GOFFLOT, S., ... HUYNEN, P. (Other coll.). (2021). Mapping the human genetic architecture of COVID-19. Nature, 600, 472-477. doi:10.1038/s41586-021-03767-x Peer Reviewed verified by ORBi |
 | Vercheval, C., Sadzot, B., MAES, N., Denooz, R., Damas, P., & FRIPPIAT, F. (2021). Continuous infusion of cefepime and neurotoxicity: a retrospective cohort study. Clinical Microbiology and Infection. doi:10.1016/j.cmi.2020.07.003 Peer Reviewed verified by ORBi |
 | Meuris, C., Kremer, C., Geerinck, A., Locquet, M., Bruyère, O., Defêche, J., Meex, C., Hayette, M.-P., Duchene, L., Dellot, P., Azarzar, S., Maréchal, N., Sauvage, A.-S., Frippiat, F., Giot, J.-B., Léonard, P., Fombellida, K., Moutschen, M., Durkin, K., ... Darcis, G. (2021). Transmission of SARS-CoV-2 After COVID-19 Screening and Mitigation Measures for Primary School Children Attending School in Liège, Belgium. JAMA Network Open, 4 (10), 2128757. doi:10.1001/jamanetworkopen.2021.28757 Peer Reviewed verified by ORBi |
Belche, J. L., Delree, G., Dessard, A., Crismer, A., Janssen, B., Spiers, S., Bolly, C., Meuris, C., GILLAIN, S., Berg, N., Frippiat, F., Bouckenaere, D., Desmedt, M., Vanhalewyn, M., Mary, Q., Adam, S., Giet, D., & Moreau, J.-F. (2020). Vademecum de prise en charge de patients COVID au sein d'institutions résidentielles. |
 | FRIPPIAT, F., Vercheval, C., & Layios, N. (2020). Meropenem: continuous or extended infusion? Critical care (London, England), 24 (1), 192. doi:10.1186/s13054-020-02883-w Peer reviewed |
 | GONCETTE, V., Layios, N., & Frippiat, F. (2020). Continuous infusion and outpatient parenteral antimicrobial therapy with ceftazidime-avibactam: evaluation of efficacy based on therapeutic drug monitoring [Paper presentation]. ECCMID 2020. Peer reviewed |
 | El Moussaoui, M., Lambert, I., MAES, N., SAUVAGE, A.-S., FRIPPIAT, F., MEURIS, C., UURLINGS, F., LECOMTE, M., LEONARD, P., Fombellida, K., VAIRA, D., Vercheval, C., Moutschen, M., & Darcis, G. (2020). Evolution of Drug Interactions With Antiretroviral Medication in People With HIV. Open Forum Infectious Diseases, 7 (11), 416. doi:10.1093/ofid/ofaa416 Peer Reviewed verified by ORBi |
 | Vercheval, C., DAMAS, P., & FRIPPIAT, F. (2020). Quality of documentation on antibiotic treatment in medical records: evaluation of the long-term impact of an antimicrobial stewardship intervention [Poster presentation]. 30th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Paris, France. |
 | Tajildin, R., MARCHETTA, S., FRIPPIAT, F., & Lancellotti, P. (2020). Endocardite infectieuse a Streptococcus agalactiae. Revue Médicale de Liège, 75 (2), 94-99. Peer reviewed |
 | TCHANA-SATO, V., HANS, G., FRIPPIAT, F., ZEKHNINI, I., DULGHERU, R. E., LAVIGNE, J.-P., & Defraigne, J.-O. (2020). surgical management of staphylococcus capitis prosthetic valve infective endocarditis: retrospective review of a 10 year single center experience and review of the literature. Journal of Infection and Public Health. doi:10.1016/j.jiph.2020.09.010 Peer Reviewed verified by ORBi |
 | El Moussaoui, M., Lambert, I., MAES, N., SAUVAGE, A.-S., FRIPPIAT, F., MEURIS, C., UURLINGS, F., LECOMTE, M., LEONARD, P., FOMBELLIDA, K., VAIRA, D., Vercheval, C., MOUTSCHEN, M., & DARCIS, G. (22 November 2019). Evolution of drug interactions with antiretroviral medications in HIV-infected patients [Poster presentation]. 8th BREACH SYMPOSIUM, Liège, Belgium. |
El Moussaoui, M., Lambert, I., MAES, N., SAUVAGE, A.-S., FRIPPIAT, F., MEURIS, C., UURLINGS, F., LECOMTE, M., LEONARD, P., Fombellida, K., VAIRA, D., Vercheval, C., MOUTSCHEN, M., & DARCIS, G. (08 November 2019). Evolution of drug interactions with antiretroviral medications in HIV-infected patients [Paper presentation]. 17th European AIDS Conference, Bâle, Switzerland. |
 | Vercheval, C., GILLET, M., Koch, N., HAYETTE, M.-P., FRIPPIAT, F., DAMAS, P., & VAN HEES, T. (2019). Utilisation de la nystatine dans la candidose oropharyngée au CHU de Liège. Journal de Pharmacie de Belgique. Peer Reviewed verified by ORBi |
 | Pirotte, B., FRIPPIAT, F., DARCIS, G., Rassenfosse, M., Fombellida, K., MAES, N., Moerman, F., & MOUTSCHEN, M. (2019). Etude des motifs d'admission au service des Urgences d'une cohorte de patients. Revue Médicale de Liège. Peer reviewed |
 | DARCIS, G., MAES, N., Pasternak, A., SAUVAGE, A.-S., FRIPPIAT, F., MEURIS, C., UURLINGS, F., LECOMTE, M., LEONARD, P., El Moussaoui, M., Fombellida, K., VAIRA, D.* , & MOUTSCHEN, M.*. (2019). Detectability of HIV residual Viremia despite therapy is highly associated with treatment with a protease inhibitor-based combination antiretroviral therapy. Antimicrobial Agents and Chemotherapy. doi:10.1128/AAC.01902-19 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | DARCIS, G., Lambert, I., SAUVAGE, A.-S., FRIPPIAT, F., MEURIS, C., UURLINGS, F., LECOMTE, M., LEONARD, P., GIOT, J.-B., fombellida, K., VAIRA, D., & MOUTSCHEN, M. (2018). Factors associated with late presentation for HIV care in a single Belgian reference center: 2006-2017. Scientific Reports. doi:10.1038/s41598-018-26852-0 Peer Reviewed verified by ORBi |
 | DESCY, J., VISEE, C., FRIPPIAT, F., MEEX, C., LAYIOS, N., VAN BAMBEKE, F., & MELIN, P. (21 April 2018). Temocillin susceptibility testing with Vitek2® system and E-test® Are these methods reliable to determine temocillin MIC ? [Poster presentation]. ECCMID 2018. |
 | HALLEUX, D., Juriens, I., Delwaide, J., FRIPPIAT, F., LEONARD, P., BLETARD, N., & DETRY, O. (February 2018). Prise en charge multidisciplinaire d'une volumineuse hydatidose hepatique. Revue Médicale de Liège, 73 (2), 65-71. Peer reviewed |
 | FRIPPIAT, F., Hayette, M.-P., & MEEX, C. (25 January 2018). L’approche syndromique : quel bénéfice pour le patient ? Application aux méningo-encéphalites [Paper presentation]. Formation continue en biologie clinique, LIEGE, Belgium. |
 | MARCHETTA, S., DULGHERU, R. E., Oury, C., FRIPPIAT, F., & Lancellotti, P. (2018). Une urgence bien souvent meconnue. Revue Médicale de Liège, 73 (5-6), 283-289. Peer reviewed |
 | VISEE, C., LAYIOS, N., MISTRETTA, V., MAES, N., VAN BAMBEKE, F., & FRIPPIAT, F. (23 April 2017). Epithelial lining fluid penetration of temocillin administered by continuous infusion in critically ill patients with nosocomial pneumonia [Paper presentation]. 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Vienne, Austria. |
 | VISEE, C., FRIPPIAT, F., DESCY, J., MEEX, C., MELIN, P., MISTRETTA, V., VAN BAMBEKE, F., & LAYIOS, N. (22 April 2017). Are Vitek2 system and E-test relevant and reliable for determining susceptibility to temocillin? [Poster presentation]. 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Vienne, Austria. |
 | Kabore, C., FRIPPIAT, F., & GILLET, P. (2017). PRISE EN CHARGE DE L’OSTÉOMYÉLITE CHRONIQUE PAR ANTIBIOTHÉRAPIE SUPPRESSIVE AU LONG COURS. Revue Médicale de Liège. Peer reviewed |
 | Deleixhe, B., FRIPPIAT, F., Léonard, P., WITHOFS, N., MEEX, C., Pierard, L., & Moutschen, M. (2017). Endocardite à aggregatibacter aphrophilus sur prothèses valvulaires. Revue Médicale de Liège, 72 (12), 522-528. Peer reviewed |
 | FRIPPIAT, F., VERCHEVAL, C., & LAYIOS, N. (01 February 2016). Decreased antibiotic consumption in the Belgian community: Is it credible? Clinical Infectious Diseases, 62 (3), 403-404. doi:10.1093/cid/civ868 Peer Reviewed verified by ORBi |
 | VERCHEVAL, C., GILLET, M., MAES, N., Albert, A., FRIPPIAT, F., Damas, P., & Van Hees, T. (2016). Quality of documentation on antibiotic therapy in medical records: evaluation of combined interventions in a teaching hospital by repeated point prevalence survey. European Journal of Clinical Microbiology and Infectious Diseases, 35 (9), 1495–1500. doi:10.1007/s10096-016-2690-0 Peer Reviewed verified by ORBi |
 | DAMAS, P., FRIPPIAT, F., ANCION, A., CANIVET, J.-L., LAMBERMONT, B., LAYIOS, N., MASSION, P., MORIMONT, P., NYS, M., PIRET, S., LANCELLOTTI, P., WIESEN, P., D'ORIO, V., SAMALEA SUAREZ, N., & LEDOUX, D. (January 2015). Prevention of ventilator-associated pneumonia and ventilator-associated conditions: A randomized controlled trial with subglottic secretion suctioning. Critical Care Medicine, 43 (1), 22-30. doi:10.1097/CCM.0000000000000674 Peer Reviewed verified by ORBi |
 | FRIPPIAT, F., Musuamba, F. T., Seidel, L., Albert, A., DENOOZ, R., Charlier, C., Van Bambeke, F., Wallemacq, P., DESCY, J., LAMBERMONT, B., LAYIOS, N., DAMAS, P., & Moutschen, M. (12 September 2014). Modelled target attainment after meropenem infusion in patients with severe nosocomial pneumonia: the PROMESSE study. Journal of Antimicrobial Chemotherapy, 70, 207-216. doi:10.1093/jac/dku354 Peer Reviewed verified by ORBi |
 | Frippiat, F., Seidel, L., Denooz, R., DAMAS, P., Layios, N., & Moutschen, M. (2014). Pharmacokinetics of Extended vs Intermittent Intravenous Infusion of Meropenem in Critically Ill Patients Receiving Continuous Veno-Venous Haemofiltration. Open Forum Infectious Diseases. doi:10.1093/ofid/ofu052 Peer Reviewed verified by ORBi |
 | KEUTGENS, A., SIMONI, P., DETREMBLEUR, N., FRIPPIAT, F., GIOT, J.-B., SPIRLET, F., AGHAZARIAN, S., DESCY, J., MEEX, C., HUYNEN, P., Melin, P., MULLER, N., GOTTSTEIN, B., CARLIER, Y., & Hayette, M.-P. (February 2013). FATAL ALVEOLAR ECHINOCOCCOSIS OF THE LUMBAR SPINE. Journal of Clinical Microbiology, 51 (2), 688-91. doi:10.1128/JCM.01906-12 Peer Reviewed verified by ORBi |
 | FRIPPIAT, F., VERCHEVAL, C., LAMBERMONT, B., & DAMAS, P. (2013). Is extended or continuous infusion of Carbapenems the obvious solution to improve clinical outcomes and reduce mortality? Clinical Infectious Diseases, 57 (2), 324-325. doi:10.1093/cid/cit205 Peer Reviewed verified by ORBi |
 | Moutschen, M., FRIPPIAT, F., CHRISTIAENS, G., & ALLEPAERTS, S. (14 June 2012). HYGIENE ET PROBLEMES INFECTIEUX EN GERIATRIE [Paper presentation]. SOIREES DU MASTER COMPLEMENTAIRE EN GERIATRIE, CHENEE (LIEGE), Belgium. |
independent Belgian/Luxembourg Working Party on Antimicrobial Therapy,, MELIN, P., Arendt, V., Cartuyvels, R., Delforge, M.-L., De Waele, J., Delaere, B., FRIPPIAT, F., Hites, M., Ieven, G., Malfroot, A., Konopnicki, D., Pierard, D., Reynders, M., Rossi, C., Tuerlinckx, D., Van Eldere, J., Verhaegen, J., & Vogelaers, D. (2012). Tables 1, 2, 3 and 4 (1-199). In The Sanford Guide to Antimicrobial Therapy 23rd edition of the Belgian/Luxembourg Version 2012-2013 (Adapted for use by the medical profession in Belgium and Luxembourg by the independent Belgian/Luxembourg Working Party on Antimicrobial Therapy (Distributed under license by the Société belge d'infectiologie et de microbiologie clinique SBIMC/BVIKM, pp. 1-500). Sperryville, United States: Jeb C. Sanford - Antimicrobial therapy Inc. Peer reviewed |
 | LAYIOS, N., LAMBERMONT, B., CANIVET, J.-L., MORIMONT, P., PREISER, J.-C., GARWEG, C., LEDOUX, D., FRIPPIAT, F., PIRET, S., GIOT, J.-B., WIESEN, P., MEURIS, C., MASSION, P., LEONARD, P., NYS, M., LANCELLOTTI, P., CHAPELLE, J.-P., & DAMAS, P. (2012). Procalcitonin usefulness for the initiation of antibiotic treatment in intensive care unit patients. Critical Care Medicine, 40 (8), 2304-9. doi:10.1097/CCM.0b013e318251517a Peer Reviewed verified by ORBi |
 | Kaux, J.-F., LENELLE, J., FRIPPIAT, F., LE GOFF, C., BARTSCH, V., Crielaard, J.-M., & DIVE, D. (August 2011). Métastase septique dorsale secondaire d’un abcès rétropharyngé responsable d’une tétraparésie. Revue Neurologique, 167 (8-9), 638-640. doi:10.1016/j.neurol.2011.03.001 Peer Reviewed verified by ORBi |
 | Moutschen, P., Bourhaba, M., FRIPPIAT, F., GIOT, J.-B., MEURIS, C., Leonard, P., & Moutschen, M. (2011). A pauci-symptomatic case of documented Hantavirus (Puumala) infection in a patient under anti-TNF treatment. Journal of Clinical Virology, 50 (3), 247-8. doi:10.1016/j.jcv.2010.11.016 Peer Reviewed verified by ORBi |
 | FRIPPIAT, F., & Moutschen, M. (2011). Syphilis treatment in the human immunodeficiency virus-infected patient: follow the guidelines. Clinical Infectious Diseases, 53 (8), 845. doi:10.1093/cid/cir513 Peer Reviewed verified by ORBi |
 | Vanmeerbeek, M., Burette, P., Giet, D., FRIPPIAT, F., & Brunet, S. (16 November 2010). Qu’avons-nous appris de la pandémie de grippe de 2009 ? [Paper presentation]. Enseignement post-universitaire, Liège, Belgium. |
Frippiat, F., Bensahi, I., Denooz, R., Charlier, C., Damas, P., & Vanbelle, S. (23 October 2010). Interest of routine dosage of meropenem in difficult to treat infections [Poster presentation]. 48th Annual Meeting of IDSA, Vancouvert, Canada. |
 | ZAOUI, K., MELIN, P., CHRISTIAENS, G., FRIPPIAT, F., & DAMAS, P. (25 June 2010). Antibiotic consumption and bacterial resistance [Paper presentation]. Congrès de la SIZ. |
 | Denooz, R., Frippiat, F., & Charlier, C. (2010). Simultaneous quantification of five Beta-lactam antibiotics in human plasma by HPLC-DAD: Clinical application for ceftazidime treatment in intensive care units. Acta Clinica Belgica, 65 (Suppl. 1), 24-30. doi:10.1179/acb.2010.105 Peer Reviewed verified by ORBi |
 | LAYIOS, N., LAMBERMONT, B., LEDOUX, D., MORIMONT, P., MASSION, P., GARWEG, C., FRIPPIAT, F., NYS, M., CHAPELLE, J.-P., & DAMAS, P. (2009). Usefulness of procalcitonin for the decision of antibiotic treatment in ICU patients. Intensive Care Medicine, 35 (Suppl 1), 82. Peer Reviewed verified by ORBi |
 | Mukeba, D., Chandrikakumari, K., Giot, J.-B., Leonard, P., Meuris, C., Frippiat, F., & Moutschen, M. (2009). Autoimmune angioneurotic edema in a patient with Helicobacter pylori infection. Helicobacter, 14 (1), 9-11. doi:10.1111/j.1523-5378.2009.00651.x Peer Reviewed verified by ORBi |
 | Frippiat, F., Chandrikakumari, K., & Moutschen, M. (2009). Gentamicin in infective endocarditis: how to use it? Clinical Infectious Diseases, 49 (2), 320-1; author reply 321. doi:10.1086/600063 Peer Reviewed verified by ORBi |
 | MORIMONT, P., FRIPPIAT, F., LANCELLOTTI, P., & LAMBERMONT, B. (2008). Comment je préviens... l'endocardite infectieuse: Une meilleure hygiène bucco-dentaire plutôt qu'une antibioprophylaxie systématique? Revue Médicale de Liège. Peer reviewed |
 | Leclercq, P., Frippiat, F., & Lambermont, B. (June 2008). Cotrimoxazole induced mixed type II cryoglobulinemia. European Journal of Internal Medicine, 19 (4). doi:10.1016/j.ejim.2007.09.008 Peer Reviewed verified by ORBi |
 | MORIMONT, P., FRIPPIAT, F., LANCELLOTTI, P., & Lambermont, B. (2008). Comment je previens...l'endocardite infectieuse: une meilleure hygiene bucco-dentaire plutot qu'une antibioprophylaxie systematique? Revue Médicale de Liège, 63 (11), 640-2. Peer reviewed |
 | Bethlen, S., Chandrikakumari, K., de Leval, L., GIOT, J.-B., Mukeba, D., Leonard, P., Frippiat, F., Meuris, C., Delwaide, J., & Moutschen, M. (2008). Chronic hepatitis C infection in a patient with bone marrow hypoplasia. World Journal of Gastroenterology, 14 (26), 4238-40. doi:10.3748/wjg.14.4238 Peer Reviewed verified by ORBi |
 | Chandrikakumari, K., Giot, J.-B., de Leval, L., Creemers, E., Leonard, P., Mukeba, D., Moutschen, M., & Frippiat, F. (2008). Report of a case of Streptococcus agalactiae mycotic aneurysm and review of the literature. International Journal of Surgical Pathology, 16 (3), 314-9. doi:10.1177/1066896907310304 Peer Reviewed verified by ORBi |
Charlier, C., Denooz, R., & Frippiat, F. (2008). Simultaneous determination of five Beta-lactam antibiotics in human plasma by HPLC-DAD: A highly performing approach of the antibiotherapy in intensive care units [Poster presentation]. BelTox, Louvain, Belgium. |
Charlier, C., Denooz, R., & FRIPPIAT, F. (2008). Amélioration de la gestion clinique et financière de l'antibiothérapie par le contrôle thérapeutique [Paper presentation]. Séance de Formation Continuée en Biologie Clinique, Liège, Belgium. |
 | Frippiat, F., Chandrikakumari, K., & Moutschen, M. (2008). Decline of antibiotic use in primary care. The Lancet Infectious Diseases, 8 (5), 272; author reply 273. doi:10.1016/S1473-3099(08)70075-6 Peer Reviewed verified by ORBi |
| Frippiat, F., GIOT, J.-B., Chandrikakumari, K., Leonard, P., Meuris, C., & Moutschen, M. (2008). Syphilis en 2008: controverses et attitudes pratiques. Revue Médicale Suisse, 4 (168), 1823-7. Peer Reviewed verified by ORBi |
 | Mayasi, N., Chandrikakumari, K., Mukeba, D., GIOT, J.-B., Leonard, P., Hayette, M.-P., Moutschen, M., & Frippiat, F. (01 September 2007). A Patient with Hiv Infection, Cough, Asthenia, and Fever. Clinical Infectious Diseases, 45 (5), 662-3, 559-600. doi:10.1086/520656 Peer Reviewed verified by ORBi |
| Frippiat, F., Waleffe, A., Soyeur, D., Leonard, P., GIOT, J.-B., & Moutschen, M. (June 2007). Uncomplicated left-sided infective endocarditis due to Escherichia coli, successfully treated with oral levofloxacin. Clinical Research in Cardiology, 96 (6), 401. Peer Reviewed verified by ORBi |
 | Leclercq, P., Betz, R., Lambermont, B., Leonard, P., & Frippiat, F. (03 February 2007). When the book is wrong. The Lancet, 9559, 369-370. doi:10.1016/S0140-6736(07)60190-1 Peer Reviewed verified by ORBi |
 | GIOT, J.-B., Mukeba Tshialala, D., Mayasi Ngongo, N., Frippiat, F., Leonard, P., & Moutschen, M. (2007). Avancees therapeutiques en pathologie infectieuse au cours de la derniere decennie. Revue Médicale de Liège, 62 (5-6, May-Jun), 377-83. Peer reviewed |
 | Chandrika, K., Dellot, P., Frippiat, F., Giot, J.-B., Leonard, P., Marée, R., Mayasi, N., Meuris, C., Mukeba Tshialala, D., Rahmouni, S., Uurlings, F., Vaira, D., Wehenkel, L., Demonty, J., & Moutschen, M. (2007). Nouvelles approches dans la prise en charge de l'infection a VIH. Revue Médicale de Liège, 62 Spec No, 47-50. Peer reviewed |
 | Hayette, M.-P., Mukeba Tschialala, D., Meex, C., Frippiat, F., Leonard, P., Huynen, P., Melin, P., & De Mol, P. (2007). Disseminated Penicillium marneffei infection contrated in China [Poster presentation]. 2nd Pan african medical mycology conference PAMMS, Cape Town, South Africa, South Africa. |
 | Zeddou, M., Rahmouni, S., Vandamme, A., Jacobs, N., Frippiat, F., Leonard, P., SCHAAF-LAFONTAINE, N., Vaira, D., Boniver, J., & Moutschen, M. (2007). Downregulation of CD94/NKG2A inhibitory receptors on CD8+ T cells in HIV infection is more pronounced in subjects with detected viral load than in their aviraemic counterparts. Retrovirology, 4, 72. doi:10.1186/1742-4690-4-72 Peer Reviewed verified by ORBi |
 | Leclercq, P., Loly, C., Giot, J.-B., Frippiat, F., Medart, L., & Malaise, M. (2007). Spondylodiscite compliquée d'un abcès du psoas. Revue Médicale Suisse, 3 (101), 620-621. Peer Reviewed verified by ORBi |
 | Schrouff, I., VALDES SOCIN, H. G., Frippiat, F., de Leval, L., Soyeur, D., Radermecker, M., & Scheen, A. (2007). Endocardite infectieuse tricuspidienne comme cause d'une fievre d'origine indeterminee. Revue Médicale de Liège, 62 (11), 654-8. Peer reviewed |
 | Bourhaba, M., GIOT, J.-B., Tshialala, D. M., Leonard, P., Frippiat, F., & Moutschen, M. (2006). L'Hantavirose fait encore parler d'elle. Revue Médicale de Liège, 61 (5-6, May-Jun), 322-8. Peer reviewed |
